The compound has small molecule chemistry rather than an amino acid sequence joined by peptide bonds. A catalog grouping cannot change that distinction. Solvent selection and analytical methods must suit the documented material. A page described as SLU-PP-332 buy online should still provide enough identity context for a laboratory to recognize that difference.
Representative product imagery. Verify the physical label and lot documentation on receipt.
Metabolic Research
SLU-PP-332
In stock·Ships in 1–2 business days
SLU-PP-332 supplied in a compact 5 mg research vial. Each unit is labeled with a traceable lot code and links to its corresponding analytical report.
Select size1 option
Select pack sizeSave 18% on kits
1 × 5 mg$73.99
In stockSelected size 5 mgSC-SLU-005
Transparent volume pricing10-vial peptide kits save 18%.
Secure checkout US & EU dispatch
Research use only acknowledgment required at checkout
Report not published
Compound context
What researchers study
SLU-PP-332 is a synthetic small molecule investigated as an estrogen related receptor agonist. It isn't a peptide, even though the phrase SLU PP 332 peptide appears in searches. This listing supplies laboratory reference material. Select a quantity based on the documented chemical identity and the needs of the validated assay, not a claim about replacing exercise.
Published mouse work examines metabolic responses associated with ERR signaling. Estrogen related receptors are not the same as estrogen receptors. The distinction matters when selecting a biological model or interpreting a pathway result. Preclinical observations can motivate mechanistic research, but they don't establish a safe human dose or an exercise benefit from this product.
Reporter assays can be affected by cell viability and direct interference with the detection system. An apparent increase in signaling needs appropriate controls before being assigned to the intended target. Solubility and matrix composition also matter for a small molecule reference. A peptide reconstitution convention should not automatically be applied to unrelated chemistry.
Scope limitCheck the small molecule identity and lot report before analytical work. Research use excludes personal administration or performance claims. The term exercise mimetic in a paper is not a guarantee that a catalog compound reproduces exercise in humans.
Serenity Compounds is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act.
Common laboratory focus
ERRs are nuclear receptors associated with transcriptional regulation. Their name does not make them interchangeable with estrogen receptors. An assay needs to specify the receptor subtype and the response being measured. A pathway associated gene pattern is not independently a demonstration of a whole body metabolic outcome.
Vehicle and reference conditions help establish background and the expected response range. An independent viability measurement can reveal whether the cells remain comparable across conditions. A second readout can investigate detector interference. Reproducible results still need to be described within the tested model rather than translated into a human dosage or exercise claim.
Quality documentation
Know what your laboratory receives.
Batch records are published for transparency and should be independently reviewed by qualified research personnel.
Current certificateSLU-PP-332 · Report not publishedSee original reportView report
- Tamper-evident packaging
- Lot and SKU traceability
- Independent analytical review
Continue exploring
